# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Membranous nephropathy

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 22 results.
Autoreactive B Cells in Membranous Nephropathy
Status: Recruiting
Last Changed: Sep 23, 2019
First Received: Sep 19, 2019
Disease(s): Membranous Nephropathy
Intervention(s): In vitro assays.
Locations: Centro di Ricerche Cliniche per le Malattie Rare " Aldo e Cele Daccò", Ranica, BG, Italy
Adrenocorticotropic Hormone in Membranous Nephropathy
Status: Recruiting
Last Changed: Apr 09, 2020
First Received: Jan 20, 2017
Disease(s): Membranous Nephropathy
Intervention(s): ACTHar
Locations: Icahn School of Medicine at Mount Sinai, New York, New York, United States
Immunopathological Analysis in a French National Cohort of Membranous Nephropathy
Status: Not yet recruiting
Last Changed: Apr 07, 2020
First Received: Mar 30, 2020
Disease(s): Membranous Nephropathy
Intervention(s): Blood sample
Personalized Medicine for Membranous Nephropathy
Status: Recruiting
Last Changed: Feb 11, 2020
First Received: Jan 15, 2019
Disease(s): Idiopathic Membranous Nephropathy
Intervention(s): Rituximab
Locations: CHU D'amiens Hôpital Sud, Amiens, France
CHU Besançon, Besançon, France
Hôpital universitaire La Cavale Blanche, Brest, France
CHU de Caen, Caen, France
CHU Gabriel Montpied, Clermont-Ferrand, France
... and 15 other locations.
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)
Status: Recruiting
Last Changed: Apr 03, 2019
First Received: Jun 08, 2018
Disease(s): Idiopathic Membranous Nephropathy
Intervention(s): Tacrolimus, Prednisone
Locations: Shanghai Xinhua Hospital affliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, Shanghai, China
Mycophenolate Mofetil Plus Steroid in the Treatment Of Patients With Progressive Idiopathic Membranous Nephropathy
Status: Recruiting
Last Changed: Mar 18, 2019
First Received: May 31, 2017
Disease(s): Idiopathic Membranous Nephropathy
Intervention(s): Mycophenolate Mofetil, Cyclosporins
Locations: Guangdong General Hospital, Guangzhou, Guangdong, China
Belimumab With Rituximab for Primary Membranous Nephropathy
Status: Recruiting
Last Changed: Jul 29, 2020
First Received: May 14, 2019
Disease(s): Membranous Nephropathy, MN
Intervention(s): Belimumab, Placebo for Belimumab, Rituximab
Locations: University of Alabama at Birmingham School of Medicine: Division of Nephrology, Birmingham, Alabama, United States
Stanford University School of Medicine: Division of Nephrology, Stanford, California, United States
The Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center:Division of Nephrology and Hypertension, Torrance, California, United States
Mayo Clinic Jacksonville: Department of Nephrology and Hypertension, Jacksonville, Florida, United States
National Institutes of Health Clinical Center, Bethesda, Maryland, United States
... and 13 other locations.
Efficacy and Safety of LNP023 Compared With Rituximab in Subjects With Idiopathic Membranous Nephropathy
Status: Recruiting
Last Changed: Aug 05, 2020
First Received: Nov 06, 2019
Disease(s): Glomerulonephritis, Membranous
Intervention(s): LNP023, Rituximab
Locations: Novartis Investigative Site, Caba, Buenos Aires, Argentina
Novartis Investigative Site, Ciudad Autonoma de Bs As, Argentina
Novartis Investigative Site, Plzen-Bory, Czechia
Novartis Investigative Site, Praha, Czechia
Novartis Investigative Site, Montpellier, France
... and 21 other locations.
A Study of the Safety, Tolerability, Pharmacokinetics and Efficacy of Treatment With AP1189 in Patients With iMN
Status: Recruiting
Last Changed: Jul 15, 2020
First Received: Jul 07, 2020
Disease(s): Idiopathic Membranous Nephropathy
Intervention(s): 100 mg AP1189, Placebo
Locations: Aarhus Universitetshospital, Aarhus, Denmark
Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy
Status: Recruiting
Last Changed: Jun 25, 2019
First Received: Mar 06, 2019
Disease(s): Tacrolimus, Idiopathic Membranous Nephropathy, Clinical Trial
Intervention(s): Tacrolimus, Prednisone
Locations: Shanghai Xinhua Hospital affliated to Shanghai Jiao Tong University, School of Medicine, Shanghai, China